↓ Skip to main content

Second or third additional chemotherapy drug for non‐small cell lung cancer in patients with advanced disease

Overview of attention for article published in Cochrane database of systematic reviews, April 2012
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
3 X users

Citations

dimensions_citation
5 Dimensions

Readers on

mendeley
26 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Second or third additional chemotherapy drug for non‐small cell lung cancer in patients with advanced disease
Published in
Cochrane database of systematic reviews, April 2012
DOI 10.1002/14651858.cd004569.pub3
Pubmed ID
Authors

Catherine Delbaldo, Stefan Michiels, Estelle Rolland, Nathalie Syz, Jean‐Charles Soria, Thierry Le Chevalier, Jean Pierre Pignon

Abstract

Randomized trials have demonstrated that adding a drug to a single-agent or to a two-agent regimen increased the tumor response rate in patients with advanced non-small cell lung cancer (NSCLC), although its impact on survival remains controversial.

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 26 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 26 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 5 19%
Student > Master 4 15%
Student > Bachelor 3 12%
Student > Postgraduate 3 12%
Professor > Associate Professor 3 12%
Other 3 12%
Unknown 5 19%
Readers by discipline Count As %
Medicine and Dentistry 12 46%
Biochemistry, Genetics and Molecular Biology 2 8%
Agricultural and Biological Sciences 2 8%
Psychology 2 8%
Mathematics 1 4%
Other 1 4%
Unknown 6 23%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 April 2012.
All research outputs
#16,106,935
of 25,457,297 outputs
Outputs from Cochrane database of systematic reviews
#10,216
of 11,499 outputs
Outputs of similar age
#106,037
of 174,458 outputs
Outputs of similar age from Cochrane database of systematic reviews
#144
of 173 outputs
Altmetric has tracked 25,457,297 research outputs across all sources so far. This one is in the 34th percentile – i.e., 34% of other outputs scored the same or lower than it.
So far Altmetric has tracked 11,499 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 40.0. This one is in the 10th percentile – i.e., 10% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 174,458 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 37th percentile – i.e., 37% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 173 others from the same source and published within six weeks on either side of this one. This one is in the 16th percentile – i.e., 16% of its contemporaries scored the same or lower than it.